Research and Markets (http://www.researchandmarkets.com/research/2gwxtd/testicular_cancer) has announced the addition of the "Testicular Cancer Forecast in 20 Major Markets 2015-2025" report to their offering.

This report provides the current incidence population for Testicular Cancer across 20 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Australia, Canada, Mexico, Turkey, Switzerland, Norway, Denmark, South Africa, Saudi Arabia, Argentina and Russia) split by male 5-year age cohort.

Along with the current incidence, the report provides an overview of the stages, locations and histopathology of Testicular Cancer tumours. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Main symptoms and co-morbidities for Testicular Cancer include:

  • Presence of lump in one testis
  • Gynecomastia
  • Pain (lower back, scrotum or lower abdomen)
  • Cryptorchidism
  • Hypospadias

Benefits of this Report:

  • Gain further insight into the incidence of the subdivided types of Testicular Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Testicular Cancer's incident population.
  • Examination of various elevated serum levels present in Testicular Cancer patients.
  • Gain an understanding of the specific markets that have the largest number of Testicular Cancer patients.

Report Structure:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Testicular Cancer Incidence

10. Stages and Location of Testicular Cancer

11. Serum Levels in Testicular Cancer

12. Abbreviations and Acronyms used in the Report

13. Patient-Based Offering

14. Online Pricing Data and Platforms

15. References

16. Appendix

For more information visit http://www.researchandmarkets.com/research/2gwxtd/testicular_cancer